Rapid immune tolerance induction following primary immunologic prophylaxis in a hemophilia A patient with high-titre inhibitor

被引：0
|
作者：
Moorehead, P. C. [1 ]
Thibeault, L. [2 ]
Tuttle, A. [3 ]
Grabell, J. [3 ]
Dwyre, L. [2 ]
Silva, M. [3 ]
James, P. [3 ]
Lillicrap, D. [3 ]
机构：
[1] Janeway Child Hlth & Rehabil Ctr, St John, NF, Canada
[2] Kingston Gen Hosp, Kingston, ON K7L 2V7, Canada
[3] Queens Univ, Kingston, ON, Canada
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2013年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1077 / 1078
页数：2
相关论文
共 50 条
  • [21] Disappearance of high titre inhibitor in congenital Hemophilia A using rituximab induction and maintenance
    Paloma, M. J. P.
    Redondo, A. M.
    Arguinano, J. M.
    Ardaiz, M. A.
    Mateos, M. C.
    Burguete, Y.
    Montoya, M. C.
    Oyarzabal, F. J.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 32 - 32
  • [22] Immune tolerance induction in Polish children with severe hemophilia A and inhibitor-high responders
    Klukowska, A.
    Laguna, P.
    HAEMOPHILIA, 2010, 16 : 74 - 75
  • [23] Immune Tolerance Induction with High-Dose FVIII and Combined Immunosuppressive Therapy in a Patient with Severe Hemophilia A and High-Titer Inhibitor
    Ranta, S.
    Petrini, P.
    HAEMOPHILIA, 2016, 22 : 95 - 95
  • [24] A Novel Approach to Immune Tolerance Induction in Hemophilia A with Factor VIII Inhibitor
    Thornburg, Courtney D.
    Ducore, Jonathan M.
    BLOOD, 2018, 132
  • [25] Rapid desensitization and subsequent immune tolerance induction in a patient with hypersensitivity and inhibitor to factor VIII
    Mitchell, William Beauregard
    HAEMOPHILIA, 2020, 26 (03) : E134 - E137
  • [26] Immune tolerance induction for inhibitor eradication in nonsevere hemophilia A: a case series
    Nusrat, Sanober
    Popuri, Niveditha
    Nagalapuram, Vishnu
    Khan, Osman
    RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2025, 9 (01)
  • [27] A low-dose immune tolerance induction (ITI) protocol incorporating immunosuppressive agents in haemophilia A children with high-titre factor VIII inhibitor and poor-ITI prognostic risk
    Li, Zekun
    Chen, Zhenping
    Cheng, Xiaoling
    Liu, Guoqing
    Wu, Xinyi
    Li, Gang
    Zhen, Yingzi
    Cai, Siyu
    Poon, Man-Chiu
    Wu, Runhui
    HAEMOPHILIA, 2021, 27 (04) : E469 - E472
  • [28] Rituximab as an adjuvant therapy to immune tolerance in a haemophilia A boy with high inhibitor titre
    Chuansumrit, A.
    Husapadol, S.
    Wongwerawattanakoon, P.
    Hongeng, S.
    Sirachainan, N.
    Pakakasama, S.
    HAEMOPHILIA, 2007, 13 (01) : 108 - 110
  • [29] SUCCESSFUL USE OF PURIFIED MONOCLONAL FACTOR-IX FOR INDUCTION OF IMMUNE TOLERANCE IN A PATIENT WITH HEMOPHILIA-B AND HEMOPHILIA-A HIGH-TITER INHIBITOR
    KATZ, J
    CASTANEDA, VL
    FAGIN, A
    THROMBOSIS AND HAEMOSTASIS, 1993, 69 (06) : 1283 - 1283
  • [30] Rationale for the use of high dose rFVIIa in a high-titre inhibitor patient with haemophilia B during major orthopaedic procedures
    Cooper, HA
    Jones, CP
    Campion, E
    Roberts, HR
    Hedner, U
    HAEMOPHILIA, 2001, 7 (05) : 517 - 522
12345